Differences in prevalence of the low and highly cytotoxic strains among serotypes reinforce the hypothesis that serotype b and c isolates of A. actinomycetemcomitans are more virulent than serotype a strains.
Diabetes has been associated with periodontitis, but the mechanisms through which
periodontal diseases affect the metabolic control remain unclear.Objective This study aimed to evaluate serum leveis of inflammatory markers, IL-8, IL-6 and
monocyte chemoattractant protein 1 (MCP-1), in type 2 diabetic patients in the
presence of chronic periodontitis. Material and Methods Forty two individuals were enrolled in this study and assigned to one of five
groups: diabetes mellitus with inadequate glycemic control and periodontitis
(DMI+P, n = 10), diabetes mellitus with adequate glycemic control and
periodontitis (DMA+P, n = 10), diabetes mellitus without periodontitis (DM, n =
10), periodontitis without diabetes (P, n=6), and neither diabetes nor
periodontitis (H, n = 6). Periodontal clinical examination included visible plaque
index (PL), gingival bleeding index (GB), probing depth (PD), attachment level
(AL) and bleeding on probing (BP). Glycemic control was evaluated by serum
concentration of glycated hemoglobin (HbAlc). Inflammatory serum markers IL-8,
IL-6 and (MCP-1) were measured by ELISA.ResultsDMI+P and DMA+P groups presented higher PD (p=0.025) and AL (p=0.003) values when
compared to the P group. There were no significant differences among groups for
IL-6, IL-8 and MCP-1 serum levels.Conclusions Although periodontitis was more severe in diabetic patients, the serum levels of
the investigated inflammatory markers did not differ among the groups.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.